Andrew Slusser

Andrew is a Senior Director in PM Group, with more than 18 years’ experience in the S&T Sector. Over the last 4 years with PM Group he has led many Biopharma, Cell & Gene Therapy projects. After 4 years growing and leading the Architecture Department for US Western Region, he has now moved into a Process Architecture SME role supporting projects both nationally and globally. His ability to support his clients in many facets of campus to targeted facility planning allows for the continuation of his clients vision to be conceptualized and successfully achieved. Andrew’s recent experiences includes designing Bayer Pharmaceutical’s multi-modality Cell and Gene Therapy modules inside the new Cell Culture Technology Center (CCTC) on the Berkeley campus. The Cell Therapy Mod, is designed to support novel Allogeneic Cell therapies targeting Parkinson’s and other devastating illnesses. Supporting Bayer in the Berkeley campus master plan transformation, from an API focus to a multi-modal biological campus leading the development and commercialization of life saving therapies, has been an exciting experience. Andrew holds a Bachelors in Architecture and a Minor in Urban Planning from the University of the Wisconsin-Milwaukee.